Skip to Content
Shadow

Executive Leadership

Executive Leadership

Alfred Altomari

Alfred Altomari
Chairman and Chief Executive Officer and Director

Mr. Altomari has served as our Chairman of the board and Chief Executive Officer since October 2016 and has been a member of our board of directors since February 2004. Mr. Altomari served as President and Chief Executive Officer from 2010 to 2016. Previously Mr. Altomari served as Agile's Executive Chairman from 2004 to 2010. From 2003 to 2008, Mr. Altomari held multiple senior management positions at Barrier Therapeutics, Inc., including Chief Commercial Officer, Chief Operating Officer, and Chief Executive Officer. In 2008, in his role as Chief Executive Officer and as a member of Barrier's board of directors, Mr. Altomari completed the successful sale of Barrier to Stiefel Laboratories, which was subsequently acquired by GlaxoSmithKline plc. From 1982 to 2003, Mr. Altomari held numerous executive roles in general management, commercial operations, business development, product launch preparation, and finance with Johnson & Johnson. Mr. Altomari also serves on the board of directors of Insmed Inc. and Baudax Bio, Inc. He previously served on the board of directors of Recro Pharm, Inc. Mr. Altomari received an M.B.A. from Rider University and his B.S. from Drexel University. He currently serves on the LeBow College of Business Advisory Board and the Board of the Charles D. Close School of Entrepreneurship at Drexel University. He currently is a member of the Board of Directors for TASK (Trenton Area Soup Kitchen).

    Robert G. Conway

    Conway
    Senior Vice President, and Chief Supply Chain Officer

    Mr. Conway has served as our Senior Vice President, Supply Chain since January 2020. Prior to that, he served as our Senior Vice President, Enterprise Planning and Information Management since October 2017, as our Senior Vice President of Operations from 2014 to 2017 and as our Chief Development Officer and Vice President of Operations from 2004 to 2014.  Mr. Conway has over thirty years of practice in U.S. and international operations with an extensive background in the medical device, pharmaceutical and consumer products industries. Mr. Conway has also previously served as Principal of R. G. Conway and Associates, an independent engineering and project management-consulting firm.  Prior to consulting in 1997, Mr. Conway began his career in healthcare with Johnson & Johnson and later joined a Johnson & Johnson supported venture-backed medical device company operating as President and Chief Operating Officer.  Mr. Conway holds a B.S. degree in Mechanical Engineering from New Jersey Institute of Technology.

      Geoffrey P. Gilmore

      Geoffrey P. Gilmore
      Senior Vice President, General Counsel and Corporate Secretary

      Mr. Gilmore has been our General Counsel since August 2014. From 2012 to April 2016, Mr. Gilmore was a principal of Life Sciences Advisory Services, providing consulting services to the pharmaceutical and life science industries. He served as Senior Vice President, General Counsel and Corporate Secretary of Amicus Therapeutics, Inc., a public bio-pharmaceutical company, from 2008 to 2012. Prior to joining Amicus, Mr. Gilmore spent 10 years at Bristol-Myers Squibb where he held roles of increasing responsibility in the legal department with the Commercial, Intellectual Property, and R&D legal groups, served in the Office of the Corporate Secretary and then reported to the General Counsel as Vice-President and Senior Counsel, Corporate Securities. Mr. Gilmore began his legal career in the business and finance groups at Philadelphia based law firms, Ballard Spahr LLP and Montgomery McCracken Walker & Rhoads LLP. Mr. Gilmore received his B.A. degree from Franklin and Marshall College, and his J.D. from the University of Michigan Law School.

        Tristen Herrstrom

        Herrstrom
        Senior Vice President, Human Resources and Administration

        Ms. Herrstrom joined Agile as Vice President, Human Resources and Administration in April 2020 and since September 2020, she has served as Senior Vice President Human Resources and Administration.  She brings over 25 years of experience building high growth organizations in the healthcare and pharmaceutical services sector.  Most recently, she served as Senior Vice President, Human Resources for Certara, a private equity-backed global leader in advancing efficient drug development, where she built the global HR function and integrated multiple companies.  From June 2012 to June 2015, Ms. Herrstrom served as Chief Resource Officer for Qualcare Alliance Networks, Inc. preparing the company for a successful sale to Cigna Healthcare in 2015.  During Ms. Herrstrom’s tenure at Syneos Health (formerly inVentiv Health) from 1998 to 2011, she held multiple positions of increasing responsibility, and integrated more than 25 acquired companies resulting in the company being purchased by Thomas H. Lee Partners in 2010.  Ms. Herrstrom earned a M.S. Degree in Human Resource Counseling from Northeastern University and holds a B.S. Degree in Psychology from The College of New Jersey.

          Paul Korner, MD, MBA

          Korner
          Chief Medical Officer

          Dr. Korner has been our Chief Medical Officer since August 2020. He has served in various leadership positions of increasing responsibility at several global companies focused on female reproductive health, including Solvay Pharmaceuticals, Wyeth Research, Bayer, and Ferring Pharmaceuticals. Dr. Korner has led more than 50 clinical trials that include multiple engagements with the U.S. Food and Drug Administration, European Medicines Agency, Pharmaceuticals and Medical Devices Agency in Japan, and Health Canada. Most recently Dr. Korner brought his clinical and development acumen to the gene therapy space as a Senior Vice President of Clinical Development & Medical Affairs at Axovant Gene Therapies, Ltd. He currently serves on the Laidlaw Venture Partners Scientific Advisory Board and the Board of Directors of Voltron Therapeutics as an Independent Director. Dr. Korner received his MD from the Stritch School of Medicine at Loyola University and also holds an MBA from the Michael J. Coles College of Business at Kennesaw State University.

            Dennis P. Reilly

            Dennis P. Reilly
            Senior Vice President and Chief Financial Officer

            Reilly has had significant experience with commercial companies in the pharmaceutical and diagnostics sectors.  In 2017, he served as Chief Financial and Chief Operating Officer of Invisible Sentinel, Inc., a private company, which BioMerieux acquired in February 2019.  From 2009 to 2017, he served as Chief Financial Officer of NeoStrata Company, Inc., a privately held global leader in dermocosmetics, which was sold to Johnson & Johnson Consumer Inc. in 2016.  From 2005 to 2008, he served as the Chief Financial Officer, and prior to that as Controller, of Barrier Therapeutics, Inc., a public dermatology focused specialty pharmaceutical company, which was sold to Stiefel Laboratories, Inc. in 2008.  Mr. Reilly was the Corporate Controller at the Medicines Company from 2002 to 2005.  In addition, held positions of increasing responsibilities at Mobil Oil Corporation, which included financial statement preparation, internal audit, SEC reporting, and financial analysis.  Mr. Reilly is a C.P.A., who received his B.S. in Accounting from Villanova and his M.B.A. from Virginia Tech.

              Amy Welsh

              Welsh
              Vice President, Marketing

              Ms. Welsh has been our Vice President of Marketing since May 2020. She brings over 25 years of industry marketing experience to Agile with a proven track record in product launch and lifecycle management. Prior to joining Agile, Ms. Welsh served for 3 years as the Vice President of Marketing at Antares Pharma Inc., a public specialty pharmaceutical company, where she oversaw the launch of its flagship brand XYOSTED, as well as the commercialization of products, strategic planning of developmental assets, as well as new M&A opportunities. Before Antares, she spent over eight years at AstraZeneca in brand management and marketing roles of increasing responsibility. Ms. Welsh also brings perspective and experience from her time working at a digital advertising agency dedicated to serving the life sciences industry. Ms. Welsh earned a dual B.A degree in Marketing Communications and English Literature from LaSalle University.

                Kimberly Whelan

                Whelan
                Vice President, Sales and Market Access

                Ms. Whelan has been our Vice President of Sales and Market Access since December 2019. She brings over 35 years of experience in various capacities in the healthcare industry, including finance, sales, marketing, business development and managed markets.  Immediately prior to joining Agile Therapeutics, Kimberly worked on Strategic Initiatives at the Health Management Academy, which is a peer learning company that convenes C-Suite executives from the top 100-US Health Systems and industry to work on solving key healthcare challenges.  After beginning her career in public accounting, Kimberly joined the finance team at Johnson and Johnson.  After her experience in finance roles, she moved to the commercial side of the business where she spent most of her career in sales, marketing, business development and managed market leadership roles.  In those roles she was responsible for delivering sales results both individually and as a sales leader, creating and executing successful pre-launch, launch and post launch marketing and managed market strategies and supporting merger, licensing, and acquisition initiatives. She worked in both the pharmaceutical and medical device businesses.  Ms. Whelan received a B.S. in Computer Science and Accounting from LaSalle University.

                  Shadow